Skip to main content

procainamide

Generic: PROCAINAMIDE HYDROCHLORIDE·Brand: PROCAINAMIDE HYDROCHLORIDE, PROCAN, PROCAN SR, PROCANBID, PROCAPAN, PRONESTYL, PRONESTYL-SR

procainamide: developed by 1 company · 1 FDA decision.

procainamide evidence translation

What we can confirm

What it means

Source-backed records connect procainamide to NEXS; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could procainamide → NEXS affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Development Pipeline (2)
CompanyPhase
NEXUS BIOPHARMA INC (NEXS)Approved
NEXUS BIOPHARMA INC (NEXS)Approved
FDA Decisions1 records
ApprovalINDICATIONS AND USAGE Procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. Because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided. Initiation of procainamide treatment, as with other ant(NEXS)FDA ↗
ANDA206332UNKNOWNStandardOtherInjectable

Frequently asked questions

Who is developing procainamide?

procainamide is being developed by NEXUS BIOPHARMA INC.

What is procainamide's latest FDA decision?

The most recent tracked FDA decision for procainamide is Approval for INDICATIONS AND USAGE Procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. Because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided. Initiation of procainamide treatment, as with other ant, dated October 13, 2017.